Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

E. Manson, JoAnn; T. Chlebowski, Rowan; L. Stefanick, Marcia; K. Aragaki, Aaron; E. Rossouw, Jacques; L. Prentice, Ross; L. Anderson, Garnet; V. Howard, Barbara; A. Thomson, Cynthia; Z. LaCroix, Andrea; Wactawski‐Wende, Jean; D. Jackson, Rebecca; C. Limacher, Marian; L. Margolis, Karen; Wassertheil‐Smoller, Sylvia; A.A. Beresford, Shirley; A. Cauley, Jane; B. Eaton, Charles; Gass, Margery; Hsia, Judith; Johnson, Karen; Kooperberg, Charles; H. Kuller, Lewis; E. Lewis, Cora; Liu, Simin; W. Martin, Lisa; K. Ockene, Judith; Jo O’Sullivan, Mary; H. Powell, Lynda; S. Simon, Michael; Van Horn, Linda; Z. Vitolins, Mara; B. Wallace, Robert

doi:10.1001/jama.2013.278040

Public

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

Published in JAMA • Oct 1, 2013

Authors:

JoAnn E. Manson

Rowan T. Chlebowski

Marcia L. Stefanick

Abstract

IMPORTANCE: Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention. OBJECTIVE: To report a comprehensive, integrated overview of findings from the 2 Women's Health Initiative (WHI) hormone therapy trials with extended...

Subject

Medicine

Women's Health Initiative

Medroxyprogesterone acetate

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!